Medline Industries, Inc. has launched the newest addition to its latex, powder-free surgical glove line, Signature Glide. This new glove features an inner gel coating made from a hydrophilic synthetic polymer that allows surgeons hands to glide effortlessly into the glove wet or dry.
Medline introduced Signature Glide in New Orleans at the 59th Annual Association of periOperative Registered Nurses (AORN) Congress, held last week. Signature Glide joins Medlines comprehensive line of latex and latex-free surgical gloves, which are made on an anatomical former design to replicate the natural hand shape. All Medline surgical gloves exceed FDA testing requirements, including thorough inspections for pinholes, tears, tensile strength and elongation.
Signature Glide comes in a translucent color, which according to AORN recommendations for double-gloving, provides excellent contrast to detect tears and pinholes. The new gloves exterior finish provides exceptional control and tactile sensitivity ideal for use in variety of procedures. With a slightly widened palm designed to reduce hand fatigue, Signature Glide also features a reinforced cuff to reduce roll down and tearing.
Medline believes that user insight is of highest priority when providing a product with premium features and exceptional design, says Paul Bottcher, president of Medlines surgical gloves division. Signature Glide provides the quality, strength and performance surgeons and staff expect out of their surgical gloves.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.